Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route

Dendritic cells (DC) presenting tumor antigens are crucial to induce potent T cell-mediated anti-tumor immune responses. Therefore DC-based cancer vaccines have been established for therapy, however clinical outcomes are often poor and need improvement. Using a mouse model of B16 melanoma, we found...

Descripción completa

Detalles Bibliográficos
Autores principales: Edele, Fanny, Dudda, Jan C., Bachtanian, Eva, Jakob, Thilo, Pircher, Hanspeter, Martin, Stefan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133283/
https://www.ncbi.nlm.nih.gov/pubmed/25121970
http://dx.doi.org/10.1371/journal.pone.0105266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133283/
https://www.ncbi.nlm.nih.gov/pubmed/25121970
http://dx.doi.org/10.1371/journal.pone.0105266

Ejemplares similares